|
Jul 29
|
ADLM announces 2025 Top Corporate Supporter Award recipients and thanks them for their vital backing
|
|
Jul 29
|
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers
|
|
Jul 29
|
Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche
|
|
Jul 28
|
Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations
|
|
Jul 26
|
Bio-Rad Laboratories, Inc. (BIO) Launches New Digital PCR Systems in 2025
|
|
Jul 24
|
Earnings Preview: Bio-Rad Laboratories (BIO) Q2 Earnings Expected to Decline
|
|
May 13
|
Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends
|
|
May 12
|
Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference
|
|
Feb 21
|
Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips
|
|
Feb 20
|
EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y
|
|
Feb 19
|
Penumbra Q4 Earnings & Revenues Top, Margins Expand, Stock Rises
|
|
Feb 18
|
Medtronic Q3 Earnings Top Estimates, Revenues Miss, Stock Tumbles
|
|
Feb 18
|
BIO Stock Might Rise Following the Offer to Acquire Stilla
|
|
Feb 17
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
|
Feb 15
|
Bio-Rad price target lowered to $447 from $477 at RBC Capital
|
|
Feb 15
|
Bio-Rad Laboratories Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 14
|
BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket
|
|
Feb 14
|
Bio-Rad set to acquire Stilla Technologies
|
|
Feb 14
|
Q4 2024 Bio Rad Laboratories Inc Earnings Call
|
|
Feb 14
|
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
|